Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 6(129), p. 2500-2513, 2019
DOI: 10.1172/jci127223
Links
Tools
Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis
Journal article published in 2019 by
Patricia Santofimia-Castaño,
Yi Xia 
,
Wenjun Lan,
Zhengwei Zhou,
Can Huang,
Ling Peng ,
Philippe Soubeyran,
Adrián Velázquez-Campoy,
Olga Abián ,
Bruno Rizzuti ,
José L. Neira,
Juan Iovanna
,
Wenjun Lan,
Zhengwei Zhou,
Can Huang,
Ling Peng ,
Philippe Soubeyran,
Adrián Velázquez-Campoy,
Olga Abián ,
Bruno Rizzuti ,
José L. Neira,
Juan Iovanna
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 